60 Minutes report claims unapproved plastic sources used in Boston Scientific pelvic meshes

Boston Scientific (NYSE:BSX) stocks fell slightly in pre-market trading after being covered in a 60 Minutes episode focused on gynecological pelvic mesh implants which are the source of a massive multi-district litigation, including claims that the company knowingly purchased inauthentic Chinese plastic materials for production. The Marlborough, Mass.-based company declined an interview with 60 Minutes, which focused on the devices and the 48,000 suits Boston Scientific faces over the allegedly harmful meshes. Boston Scientific was quoted as having told 60 Minutes that “nearly one million women have been successfully treated […] We have extensively tested the [plastic] resin to confirm its composition, safety and performance.” The statement won support from the American Urogynecological Society, but other expert sources interviewed by 60 Minutes had contrasting opinions. Dr. Michael Margolis, a surgeon who has reportedly removed 350 mesh implants and has served as a witness in lawsuits against Boston Scientific, claimed that the meshes cause a chronic inflammatory reaction. “The slings I’ve removed are substantially altered in their architecture. They are shrunk by at least 50% in width; they are encased in scar tissue. The pores here, these openings here are shrunk substantially,” Dr. Margolis said, according to 60 Minutes. The report claims that Boston Scientific won FDA clearance for and used “Marlex” branded polypropylene, made by ...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Legal News Women's Health Boston Scientific Source Type: news